Obsidian Therapeutics
- Market cap
- 815.40M
- P/E (TTM)i
- 20.31
- P/Bi
- 2.32
- EPSi
- 0.65
- Div yieldi
- 0.00%
- 52W posi
- 3%
Anonymous reader poll. Unscientific, not investment advice.
Obsidian Therapeutics last traded at 13.20, down 0.15% on the session. Its market capitalisation is about 815.40M, the #3403 most valuable US-listed company we track. The trailing P/E of 20.31 is 42% above its five-year average of 14.31. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 42.67 (+223% from here). The shares sit 3% of the way up their 52-week range of 12.16 to 49.97.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 21% percentile of its own 5-year range.
- Analyst consensus across 4 analysts is Buy.
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 0.4% of float.
- Analyst tilt is Buy.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Key statistics
Price & volume
- Prev close
- 13.22
- Open
- 13.02
- Day range
- 12.80 - 13.88
- Avg price
- 13.42
- Volume
- 359.04K
- Turnover
- 4.82M
- Turnover ratei
- 0.68%
- Volume ratioi
- 1.31
- Amplitudei
- 8.17%
- 52-week rangei
- 12.16 - 49.97
Valuation
- P/Ei
- 20.31
- P/E (TTM)i
- 20.31
- P/Bi
- 2.32
- EPSi
- 0.65
- Book value / shi
- 5.68
- Net profit
- 40.15M
- Net assets
- 350.99M
Share structure
- Market cap
- 815.40M
- Float capi
- 699.00M
- Shares out
- 61.77M
- Float sharesi
- 52.95M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
73.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-1.14M net over the window
Short interest
- Shares short
- 253.08K
- % of floati
- 0.41%
- Days to coveri
- 1.00
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Obsidian Therapeutics (OBX)?
Obsidian Therapeutics last traded at 13.20. The quote on this page refreshes every few seconds while US markets are open.
What is Obsidian Therapeutics's market cap?
About 815.40M.
What is the P/E ratio of Obsidian Therapeutics?
The trailing twelve-month P/E is 20.31, above its own 5-year average of 14.31 — in the middle of its historical range (36.17% percentile). See the Valuation tab for the full history.
Does Obsidian Therapeutics pay a dividend?
Obsidian Therapeutics does not currently pay a regular dividend.
Is Obsidian Therapeutics a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 42.67, which implies 223.3% upside from the current price. This is not investment advice.
Quote time 2026-10-08 08:11:02 · For reference only, not investment advice and not tailored to your situation.